Carmell Therapeutics Corp - US shares owned by UBS Group
Quarter-by-quarter ownership of Carmell Therapeutics Corp - US (CTCXW) shares owned by UBS Group
from 13F filings
Historical chart of UBS Group investment in Carmell Therapeutics Corp - US
Tip: Access up to 7 years of quarterly data
All positions including Carmell Therapeutics Corp - US held by UBS Group consolidated in one spreadsheet with up to 7 years of data
Download as csv

Quarterly reported holdings in Carmell Therapeutics Corp - US by UBS Group
Quarter filed | Position value | Share count | Share price at filing |
---|---|---|---|
2024-12-31 | $4 | 116 | 0.04 |
2024-09-30 | $493 | 9.0k | 0.06 |
2024-06-30 | $8 | 131 | 0.07 |
2023-09-30 | $569 | 2.7k | 0.21 |
Top funds holding Carmell Therapeutics Corp - US
View all funds holding Carmell Therapeutics Corp - US